Cardiac Diagnostic System by Bionetek: Early Cardiac Diagnostic System

Bionetek developed the CARDx Early Cardiac Diagnostic (ECD) System, a technological BREAKTHROUGH for patients, doctors, hospitals, and insurance companies in an effort to address the catastrophic impact of Cardiovascular Disease throughout the U.S. and the World.

The #1 killer and cause for disability in the world-over 900,000 deaths in the US/2.4 million worldwide annually and debilitating nearly 4.5 million Americans annually.

Over 65 million physician office visits annually, 7 million outpatient visits and 4 million emergency room visits, result in a primary diagnosis of Coronary Artery Disease (CAD).

Approximately 23% of myocardial infarctions go unrecognized.

The #1 healthcare expense – U.S. and other developed countries. Cardiovascular problems contributed to $26 billion in payments to Medicare beneficiaries for hospital expenses in 1999.

Bionetek introduces the CARDx Early Cardiac Diagnostic System (ECD), a non-invasive cardio-diagnostic tool that will have a major impact on heart disease through early detection of:

Coronary Artery Disease
Myocardial Infarction
Left Ventricular Dysfunction
Left Ventricular Hypertrophy
Conduction Abnormalities
Arrhythmia
Pulmonary Heart Disease

The CARDx ECD system generates a full diagnostic report of the coronary and myocardial condition in plain language, and the procedure takes less than 2 minutes to complete.